Allowed claims address core system elements of Aushon’s microarray printing technology and architecture

BILLERICA, Mass.–Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis has announced that its request for a U.S. patent covering its advanced microarray printing technology has been approved.

“The allowed claims of the patent cover important elements of our printing technology,” said Pete Honkanen, CEO of Aushon. “It’s these elements, embodied in Aushon’s 2470 Arrayer, that enable the print quality, ease of use, and probe & substrate flexibility that our customers require for their multiplexed assay applications.”

The 2470 Arrayer has been installed in leading research institutions throughout North America, Europe and Asia to provide rapid, accurate, high-density microarray printing for both genomic and proteomic applications. It is able to print virtually any sample – including cell lysates and blood – onto a wide range of substrate formats and coatings, including nitrocellulose and silicon chips. Engineered with walk-away automation, the 2470 Arrayer, with its unique solid pin architecture and proprietary pin design, is the most flexible and reliable microarray printing platform available.

About Aushon BioSystems

Aushon BioSystems provides a comprehensive suite of microarray instruments, consumables and services to leading pharmaceutical, biotechnology, academic and diagnostic clients worldwide. Our unique combination of advanced microarray printing technology, robust biomarker content and innovative multiplex immunoassay development and detection systems delivers exceptional performance, quality and reliability that accelerates pre-clinical and clinical biomarker research. Our customers trust us to provide the most reliable protein biomarker data available, which lowers costs and improves research productivity. For more information, please visit www.aushon.com.